Jilin Jian Yisheng Stock Hits Day Low Amid Price Pressure at CNY 7.21

Jilin Jian Yisheng Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 8.12% and reaching an intraday low of CNY 7.21. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% during the same period. Over the past week, Jilin Jian Yisheng has seen a more pronounced decline of 14.12%, while its one-month performance reflects a decrease of 12.98%. Year-to-date, the stock has declined by 5.11%, and its three-year performance shows a drop of 12.03%. In stark contrast, the China Shanghai Composite has gained 16.02% over the same three-year period. The company's financial metrics indicate ongoing challenges, with net sales declining at an annual rate of 6.34% and operating profit decreasing by 17.43% over the last five years. Additionally, the company has reported negative results for the last four consecutive quarters, with operating cash flow at its lowest point of CNY 71.1 million. The return on equity stands at 1.88%, and the price-to-book ratio is 0.76, reflecting the company's current market position within the pharmaceuticals and biotechnology sector.